New blood test detects 90% of aggressive prostate cancer cases, beating current screenings

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

New blood test detects aggressive prostate cancer more accurately than PSA, study finds

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...
Business Wire

MiraDx Launches New Genetic Test Expanding Radiation Therapy Risk Assessment for Prostate Cancer Patients

LOS ANGELES--(BUSINESS WIRE)--MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new ...

Breakthrough blood test detects aggressive prostate cancer with greater accuracy

A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...
360Dx

Florida Awards OTraces $2M to Support Clinical Study of Proteomic Prostate Cancer Test

The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.